India Glycols Ltd Upgraded to Hold as Technicals Improve Despite Expensive Valuation

Technical Trends Turn Mildly Bullish

The most significant catalyst for the rating upgrade is the change in the technical grade from sideways to mildly bullish. Key momentum indicators have shifted favourably over recent weeks. The Moving Average Convergence Divergence (MACD) on both weekly and monthly charts is bullish, signalling strengthening upward momentum. Similarly, Bollinger Bands on weekly and monthly timeframes have turned bullish, indicating increased price volatility in an upward direction.

Other technical signals present a more nuanced view. The Relative Strength Index (RSI) remains neutral on both weekly and monthly charts, suggesting no immediate overbought or oversold conditions. The daily moving averages, however, remain mildly bearish, reflecting some short-term caution. The Know Sure Thing (KST) indicator is mildly bullish weekly but mildly bearish monthly, while Dow Theory assessments are mildly bullish across both timeframes. On-Balance Volume (OBV) readings are bullish weekly and monthly, indicating strong buying interest.

These mixed but predominantly positive technical signals have contributed to a more optimistic near-term outlook, supporting the upgrade to a Hold rating. The stock price has responded accordingly, rising 3.83% on the day to ₹1,136.25, approaching its 52-week high of ₹1,222.85.

Valuation Shifts to Expensive Territory

While technicals have improved, valuation metrics have moved in the opposite direction, prompting a downgrade in the valuation grade from attractive to expensive. India Glycols currently trades at a price-to-earnings (PE) ratio of 28.35, which is elevated compared to many peers in the commodity chemicals industry. The price-to-book value stands at 3.20, and the enterprise value to EBITDA ratio is 15.31, both indicating a premium valuation.

Other valuation ratios include an EV to EBIT of 19.97 and an EV to capital employed of 2.21. The company’s PEG ratio is 1.45, suggesting that while earnings growth is factored into the price, the stock is not cheap relative to its growth prospects. Dividend yield remains modest at 1.06%, reflecting limited income appeal for yield-focused investors.

Compared to peers such as Navin Fluorine International and Himadri Speciality Chemical, which are rated very expensive with PE ratios above 40, India Glycols is somewhat more reasonably priced but still firmly in the expensive category. This valuation premium is partly justified by the company’s consistent earnings growth and strong returns over recent years.

Financial Trend: Mixed Signals from Growth and Profitability

India Glycols has demonstrated positive financial performance in recent quarters, with the latest six-month profit after tax (PAT) at ₹133.25 crores, reflecting a robust growth rate of 25.09%. The company has reported positive results for four consecutive quarters, underscoring operational stability. Return on capital employed (ROCE) for the half-year period is at a healthy 11.46%, while return on equity (ROE) stands at 10.83%, indicating moderate profitability.

However, some concerns remain. The company’s debt servicing ability is limited, with a high debt to EBITDA ratio of 3.56 times, signalling elevated leverage risk. Net sales growth over the past five years has been modest at an annualised rate of 9.85%, which may constrain long-term expansion potential. The average ROE of 9.08% over recent years points to relatively low profitability per unit of shareholder funds.

Despite these challenges, India Glycols has delivered impressive returns to shareholders, outperforming the BSE500 index consistently over the last three years. The stock has generated a 64.69% return in the past year alone, compared to a negative 3.59% return for the Sensex. Over a decade, the stock’s cumulative return exceeds 2,400%, vastly outpacing the benchmark’s 208.56%.

Quality Assessment: Stable but Not Outstanding

The company’s quality metrics remain steady but do not warrant a strong upgrade. The debtor turnover ratio is high at 30.92 times, indicating efficient receivables management. However, the company’s relatively high leverage and moderate profitability metrics temper the overall quality assessment. The Mojo Score of 58.0 and a Mojo Grade of Hold reflect this balanced view, improved from a previous Sell rating but still short of a Buy recommendation.

India Glycols’ small-cap status and limited domestic mutual fund ownership—only 0.51%—suggest that institutional investors remain cautious, possibly due to valuation concerns or the company’s growth prospects. This limited institutional interest may also reflect the company’s niche position within the commodity chemicals sector.

Technical Outlook and Market Performance

India Glycols’ recent price action has been strong, with the stock gaining 8.92% over the past week and 26.81% in the last month, significantly outperforming the Sensex’s 1.21% and 4.33% respective gains. Year-to-date, the stock has risen 11.51%, while the Sensex has declined 8.66%. This momentum is supported by the technical indicators discussed earlier and reflects growing investor confidence.

The stock’s 52-week trading range between ₹676.10 and ₹1,222.85 highlights substantial volatility but also significant upside potential. Today’s intraday high of ₹1,146.55 and low of ₹1,091.70 show continued buying interest near recent highs.

Conclusion: Hold Rating Reflects Balanced View

The upgrade of India Glycols Ltd’s investment rating from Sell to Hold encapsulates a balanced assessment of the company’s current position. Improved technical indicators and strong recent returns support a more positive near-term outlook. However, expensive valuation metrics, moderate financial growth, and leverage concerns limit enthusiasm for a Buy rating.

Investors should weigh the company’s consistent earnings growth and market outperformance against its premium valuation and debt profile. The Hold rating suggests that while India Glycols is no longer a sell, cautious investors may prefer to monitor developments or consider alternative opportunities within the commodity chemicals sector.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →